Edric Engert

Edric Engert is Managing Director of Abraxeolus Consulting and Venture Partner at Social Impact Capital while holding part-time Executive roles at several start-ups. His focus is growth and turnarounds through strategy, its operationalization, business development/in-licensing, portfolio strategy, selection, and management, commercialization of products, commercial infrastructure building, operational improvement programs, and M&A. He has advised a broad range of clients with Life Sciences his primary focus including Branded Pharmaceuticals, Specialty Pharma, Biosimilars, and Generics in both the Corporate and Private Equity settings. Other industries include Trade Associations, Healthcare Information Exchanges, medical supply companies, distributors, physician groups, Academic Medical Centers, Health Plans, and not-for-profit agencies.

Prior roles included Head of the Biosimilars Business at Teva, Global Head of Portfolio Management & In-licensing for Teva’s Generics business, Global Head of Portfolio Management & In-licensing at Sandoz, VP of Strategic Planning, Portfolio, and API Sourcing at Geneva Pharmaceuticals, and Engagement Manager at McKinsey & Company’s health care practice. Edric holds an MBA from Wharton and a BS in Mathematics from MIT.